Skip to Main Content

Author Details

Thomas Roetzer
Medical University of Vienna
2000
38
14
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37112888Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence.Viruses2023
35149260Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization.Photodiagnosis Photodyn Ther2022
35766206Clinico-pathologic predictors of dismal course in atypical meningiomas: a retrospective single-centre analysis.J Neurosurg Sci2022
35356207DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case-Control Study.Front Oncol2022
32608510High Diagnostic Accuracy of Visible 5-ALA Fluorescence in Meningioma Surgery According to Histopathological Analysis of Tumor Bulk and Peritumoral Tissue.Lasers Surg Med2021
33546427Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases.Cancers (Basel)2021
33540564Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma.Cancers (Basel)2021
33562253Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas.Cancers (Basel)2021
34624861The meningioma surface factor: a novel approach to quantify shape irregularity on preoperative imaging and its correlation with WHO grade.J Neurosurg2021
34595120Fluorescence Lifetime Imaging and Spectroscopic Co-Validation for Protoporphyrin IX-Guided Tumor Visualization in Neurosurgery.Front Oncol2021
34678775Influence of dexamethasone on visible 5-ALA fluorescence and quantitative protoporphyrin IX accumulation measured by fluorescence lifetime imaging in glioblastomas: is pretreatment obligatory before fluorescence-guided surgery?J Neurosurg2021
34562035Neuropathological Variability within a Spectrum of NMDAR-Encephalitis.Ann Neurol2021
34830859Reply to Stummer, W.; Thomas, C. Comment on "Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540".Cancers (Basel)2021
340642225-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers.Cancers (Basel)2021
31049574Is Intraoperative Pathology Needed if 5-Aminolevulinic-Acid-Induced Tissue Fluorescence Is Found in Stereotactic Brain Tumor Biopsy?Neurosurgery2020
32096368Surgical microscope with integrated fluorescence lifetime imaging for 5-aminolevulinic acid fluorescence-guided neurosurgery.J Biomed Opt2020
33110138Distributed changes of the functional connectome in patients with glioblastoma.Sci Rep2020
33235233Macroscopic fluorescence-lifetime imaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors.Sci Rep2020
32977210High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI.Neuroimage Clin2020
32821937Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.Hum Mol Genet2020
32730972Postoperative Magnetic Resonance Imaging After Surgery of Brain Metastases: Analysis of Extent of Resection and Potential Risk Factors for Incomplete Resection.World Neurosurg2020
32722247TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.Cancers (Basel)2020
32640583Improved Diagnostic Imaging of Brain Tumors by Multimodal Microscopy and Deep Learning.Cancers (Basel)2020
32206431Towards real-time wide-field fluorescence lifetime imaging of 5-ALA labeled brain tumors with multi-tap CMOS cameras.Biomed Opt Express2020
32560244Sex-Specific Differences in Primary CNS Lymphoma.Cancers (Basel)2020
31558656Evaluation of the radiosurgical treatment of cerebral arteriovenous malformations: a retrospective single-center analysis of three decades.J Neurointerv Surg2020
30636030Widefield fluorescence lifetime imaging of protoporphyrin IX for fluorescence-guided neurosurgery: An ex vivo feasibility study.J Biophotonics2019
31661065Multicentric malignant glioma with striking morphologic heterogeneity and early and extensive metastatic spread to the bone.Clin Neuropathol2019
30772399High-resolution metabolic mapping of gliomas via patch-based super-resolution magnetic resonance spectroscopic imaging at 7T.Neuroimage2019
30851467Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk Factor for Recurrent Hemorrhage.World Neurosurg2019
30994047Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.Acta Oncol2019
30365968Evaluating cellularity and structural connectivity on whole brain slides using a custom-made digital pathology pipeline.J Neurosci Methods2019
29319489Spatiotemporal evolution of a low-grade glioma with divergent oligodendroglial and astrocytic lineages.Clin Neuropathol2018
30150718The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.Nat Med2018
298527705-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.Neurosurg Focus2018
30258667Beyond backscattering: optical neuroimaging by BRAD.Biomed Opt Express2018
29077933Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.Neuro Oncol2018
10993559Phenology in central Europe--differences and trends of spring phenophases in urban and rural areas.Int J Biometeorol2000
  • 1 - 38 of 38

Recommended Authors

Felix Behling
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2015
Number of shared co-authors 1
Calixto-Hope G Lucas
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 8
Suganth Suppiah
University Health Network, University of Toronto
Career Start Year 2013
Number of shared co-authors 1
Justin Z Wang
University of Toronto
Career Start Year 2013
Number of shared co-authors 1
Farshad Nassiri
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 1
David R Raleigh
University of California san francisco
Career Start Year 2010
Number of shared co-authors 7
Rohan Ramakrishna
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 2
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 2
Benedikt Wiestler
Technical University
Career Start Year 2007
Number of shared co-authors 7
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Nancy Ann Oberheim Bush
University of California san francisco
Career Start Year 2005
Number of shared co-authors 8
David J Pisapia
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year 2004
Number of shared co-authors 0
Analiz Rodriguez
University of Arkansas for Medical Sciences
Career Start Year 2004
Number of shared co-authors 0
Gelareh Zadeh
University of Toronto
Career Start Year 2003
Number of shared co-authors 11
Martin Glas
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 4
Raymond Y Huang
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2002
Number of shared co-authors 7
Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2002
Number of shared co-authors 3
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 5
Jo??lle Lacombe
centre hospitalier Sainte-Anne
Career Start Year 1999
Number of shared co-authors 0
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 12
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 6
Clark C Chen
University of Minnesota
Career Start Year 1994
Number of shared co-authors 1
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 5
Tom Mikkelsen
Ontario Brain Institute
Career Start Year 1990
Number of shared co-authors 5
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 10
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 5
Kenneth Aldape
National Cancer Institute
Career Start Year 1985
Number of shared co-authors 13
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 5
Pascale Varlet
Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM, University of Paris
Career Start Year 1963
Number of shared co-authors 5

Collaborators

Georg Widhalm
Medical University of Vienna
Co-authored papers 24
Barbara Kiesel
Medical University of Vienna
Co-authored papers 23
Julia Furtner
Medical University of Vienna
Co-authored papers 15
Adelheid Woehrer
Medical University of Vienna
Co-authored papers 15
Mario Mischkulnig
Medical University of Vienna
Co-authored papers 11
Johannes A Hainfellner
Medical University of Vienna
Co-authored papers 10
Matthias Preusser
Medical University of Vienna
Co-authored papers 9
Anna S Berghoff
Co-authored papers 6
Engelbert Knosp
Medical University of Vienna
Co-authored papers 5
Stefan Oberndorfer
Karl Landsteiner University of Health Sciences
Co-authored papers 5
Franz Marhold
Karl Landsteiner University of Health Sciences
Co-authored papers 5
Wolfgang Drexler
Center for Medical Physics and Biomedical Engineering, Medical University of Vienna
Co-authored papers 5
Patrizia Moser
Medical University of Innsbruck
Co-authored papers 4
Georg Langs
Medical University of Vienna
Co-authored papers 4
Christine Marosi
Medical University of Vienna
Co-authored papers 4
Camillo Sherif
Karl Landsteiner University of Health Sciences
Co-authored papers 4
Karl-Heinz Nenning
Medical University of Vienna
Co-authored papers 4
Mitchel S Berger
University of California san francisco
Co-authored papers 4
Marco Augustin
Center for Medical Physics and Biomedical Engineering, Medical University of Vienna
Co-authored papers 4
Melitta Kitzwoegerer
Karl Landsteiner University of Health Sciences
Co-authored papers 4
Bernhard Baumann
Medical University of Vienna, Center for Medical Physics and Biomedical Engineering
Co-authored papers 4
Serge Weis
Kepler University Hospital, Johannes Kepler University
Co-authored papers 3
Nadine Peter
Institute of Neurology, Medical University of Vienna
Co-authored papers 3
Johannes Trenkler
Institute of Neuroradiology, Kepler University Hospital Linz
Co-authored papers 3
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Co-authored papers 3
Tanisa Brandner-Kokalj
Institute of Pathology, State Hospital Klagenfurt
Co-authored papers 3
Astrid E Grams
Medical University of Innsbruck
Co-authored papers 3
Joanna J Phillips
University of California san francisco
Co-authored papers 3
Waltraud Kleindienst
Paracelsus Medical University Salzburg
Co-authored papers 2
G??nther Stockhammer
Medical University of Innsbruck
Co-authored papers 2
Release 1.2